Novel therapeutic strategy for uterine endometrial cancers

International Journal of Clinical Oncology

Volumn 13, Issue 5, 2008, Pages 411-415

  Fujimoto, Jiro ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Angiogenic factors (VEGF, thymidine phosphorylase, COX 2, basic FGF, IL 8); Angiogenic inhibitor; Endometrial cancers; ETS 1; Sex steroids

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN; BASIC FIBROBLAST GROWTH FACTOR; CYCLOOXYGENASE 2; ENZYME INHIBITOR; FUMAGILLOL CHLOROACETYLCARBAMATE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 8; MEDROXYPROGESTERONE ACETATE; THYMIDINE PHOSPHORYLASE; THYMIDINE PHOSPHORYLASE INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

ANGIOGENESIS; CANCER CELL; CANCER INHIBITION; CANCER STAGING; ENDOMETRIUM CANCER; HORMONAL THERAPY; HUMAN; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR VASCULARIZATION; TUMOR VOLUME; UTERUS CANCER;

ANGIOGENESIS INDUCING AGENTS; ANGIOGENESIS INHIBITORS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEIN C-ETS-1;

EID: 54849424383     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-008-0825-8     Document Type: Review

References (41)

1. J. Folkman 1985 Tumor angiogenesis Adv Cancer Res 43 175 203
2. J. Fujimoto S. Ichigo M. Hori 1997 Expression of basic fibroblast growth factor and its mRNA in advanced uterine cervical cancers Cancer Lett 111 21 26
3. J. Fujimoto M. Hori S. Ichigo 1995 Expression of basic fibroblast growth factor and its mRNA in uterine endometrial cancers Invasion Metastasis 15 203 210
4. J. Fujimoto S. Ichigo H. Sakaguchi 1999 The expression of platelet-derived endothelial cell growth factor in uterine cervical cancers Br J Cancer 79 1249 1254
5. J. Fujimoto H. Sakaguchi R. Hirose 1999 Clinical implication of expression of platelet-derived endothelial cell growth factor (PD-ECGF) in metastatic lesions of uterine cervical cancers Cancer Res 59 3041 3044
6. J. Fujimoto H. Sakaguchi I. Aoki 2000 The value of plateletderived endothelial cell growth factor as a novel predictor of advancement of uterine cervical cancers Cancer Res 60 3662 3665
7. J. Fujimoto S. Ichigo H. Sakaguchi 1998 Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine endometrial cancers Cancer Lett 130 115 120
8. J. Fujimoto H. Sakaguchi R. Hirose 1999 Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers Br J Cancer 80 827 833
9. J. Fujimoto S. Ichigo R. Hirose 1998 Expressions of vascular endothelial growth factor (VEGF) and its mRNA in uterine endometrial cancers Cancer Lett 134 15 22
10. J. Fujimoto H. Sakaguchi I. Aoki 2000 Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers Cancer Res 60 2632 2635
11. J. Fujimoto I. Aoki S. Khatun 2002 Clinical implications of interleukin-8 related to myometrial invasion with angiogenesis in uterine endometrial cervical cancers Ann Oncol 13 430 434
12. H. Toyoki J. Fujimoto E. Sato 2005 Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in uterine endometrial cancers Ann Oncol 16 52 55
13. J. Fujimoto S. Ichigo H. Sakaguchi 1998 Expression of platelet-derived endothelial cell growth factor in uterine endometrium during the menstrual cycle Mol Hum Reprod 4 509 513
14. J. Fujimoto H. Sakaguchi R. Hirose 1999 Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells Cancer Lett 141 63 71
15. R. Rochels 1984 Pathobiochemical aspects of corneal neovascularization Fortschr Med 102 101 102
16. S. Harada J.A. Nagy K.A. Sullivan 1994 Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts J Clin Invest 93 2490 2496
17. C. Sunderkotter K. Steinbrink M. Goebeler 1994 Macrophages and angiogenesis J Leukoc Biol 55 410 422
18. P. Ben-Av L.J. Crofford R.L. Wilder 1995 Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis FEBS Lett 372 83 87
19. C. Suri P.F. Jones S. Patan 1996 Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis Cell 87 1171 1180
20. T. Asahara D. Chen T. Takahashi 1998 Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization Circ Res 83 233 240
21. G.L. Wang G.L. Semenza 1995 Purification and characterization of hypoxia-inducible factor 1 J Biol Chem 270 1230 1237
22. L.E. Huang Z. Arany D.M. Livingston 1996 Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit J Biol Chem 271 32253 32259
23. P.J. Kallio I. Pongratz K. Gradin 1997 Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor Proc Natl Acad Sci USA 94 5667 5672
24. M. Ema S. Taya N. Yokotani 1997 A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development Proc Natl Acad Sci USA 94 4273 4278
25. P.H. Maxwell G.U. Dachs J.M. Gleadle 1997 Hypoxiainducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth Proc Natl Acad Sci USA 94 8104 8109
26. P. Carmeliet Y. Dor J.M. Herbert 1998 Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis Nature 394 485 490
27. H.E. Ryan J. Lo R.S. Johnson 1998 HIF-1 alpha is required for solid tumor formation and embryonic vascularization EMBO J 17 3005 3015
28. J. Fujimoto S.M. Alam I. Jahan 2006 Plausible linkage of hypoxia inducible factors (HIF)-1α in uterine cervical cancers Cancer Sci 97 861 867
29. N. Wernert M.B. Raes P. Lassalle 1992 c-ets proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans Am J Pathol 140 119 127
30. I. Kola S. Brookes A.R. Green 1993 The Ets-1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenic process such as organ formation Proc Natl Acad Sci USA 90 7588 7592
31. I.G. Maroulakou T.S. Papas J.E. Green 1994 Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis Oncogene 9 1511 1565
32. C. Iwasaka K. Tanaka M. Abe 1996 Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells J Cell Physiol 169 522 531
33. K. Tanaka M. Abe Y. Sato 1999 Roles of extracellular signalregulated kinase 1/2 and p38 mitogen-activated protein kinase in the signal transduction of basic fibroblast growth factor in endothelial cells during angiogenesis Jpn J Cancer Res 90 647 654
34. N. Oda M. Abe Y. Sato 1999 ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3 J Cell Physiol 178 121 132
35. Y. Sato M. Abe K. Tanaka 2000 Signal transduction and transcriptional regulation of angiogenesis Adv Exp Med Biol 476 109 115
36. J. Fujimoto I. Aoki H. Toyoki 2002 Clinical implications of ETS-1 related to angiogenesis in uterine cervical cancers Ann Oncol 13 1598 1604
37. J. Fujimoto I. Aoki H. Toyoki 2002 Clinical implications of ETS-1 related to angiogenesis in uterine endometrial cancers Ann Oncol 13 1605 1611
38. R.M. Strieter S.L. Kunkel D.A. Arenberg 1995 Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis Biochem Biophys Res Commun 210 51 57
39. E. Sato J. Fujimoto H. Toyoki 2007 Expression of IP-10 related to angiogenesis in uterine cervical cancers Br J Cancer 96 1735 1739
40. E. Sato J. Fujimoto T. Tamaya 2007 Expression of interferon-gamma- inducible protein-10 related to angiogenesis in uterine endometrial cancers Oncology-Basel 73 246 251
41. J. Fujimoto M. Hori S. Ichigo 1997 Plausible novel therapeutic strategy of uterine endometrial cancer with reduction of basic fibroblast growth factor secretion by progestin and O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470) Cancer Lett 113 187 194